FDAnews Drug Daily Bulletin

ONYX TO SELL 5 MILLION SHARES

Nov. 15, 2005
A A

Biotechnology company Onyx Pharmaceuticals Inc. said Monday it plans to sell 5 million shares to the public. The company said it has granted an over-allotment option to Morgan Stanley & Co. Inc. and Merrill Lynch & Co., which underwrote the sale, to buy another 750,000 shares. All the shares will be sold by Onyx, the company said. Onyx shares closed at $27.63 on the Nasdaq Friday.

MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=AP&Date=20051114&ID=5277143)